N/A
Completed N=235
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk
Source: ClinicalTrials.gov NCT04257474 ↗Enrolled (actual)
235
Serious AEs
—
Results posted
Mar 2024
Primary outcomePrimary: Reporting Receipt of MRI Breast Screening at Any Time — 32.34 percentage of participants
Summary
This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider recommendation).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Reporting Receipt of MRI Breast Screening at Any Time |
32.34 | — |
| PRIMARY Reporting Receipt of MRI Breast Screening in the Last 24 Months |
25.11 | — |
| SECONDARY Reporting Receipt of Mammogram |
71.06 | — |
| SECONDARY Reporting Receipt of Ultrasound |
34.04 | — |
| SECONDARY Reporting Receipt of Chemoprevention |
18.30 | — |
| SECONDARY Reporting Receipt of Genetic Testing |
42.99 | — |
| SECONDARY Reporting Receipt of Genetic Counseling |
39.57 | — |
Eligibility Criteria
Inclusion Criteria
- Ability to speak/read English
- Within 2 years of last screening mammogram
- Pathogenic BRCA1/2 mutations OR estimated lifetime risk ≥20% per the National Cancer Institute (NCI) Breast Cancer Risk Assessment Tool (BCRAT)
Exclusion Criteria
- Women who have received a prior diagnosis of breast cancer
Data sourced from ClinicalTrials.gov (NCT04257474). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.